Fasting alters the gut microbiome reducing blood pressure and body weight in metabolic syndrome patients.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Avery, Ellen G
Lesker, Till Robin
Müller, Dominik N
Forslund, Sofia K
MetadataShow full item record
AbstractPeriods of fasting and refeeding may reduce cardiometabolic risk elevated by Western diet. Here we show in the substudy of NCT02099968, investigating the clinical parameters, the immunome and gut microbiome exploratory endpoints, that in hypertensive metabolic syndrome patients, a 5-day fast followed by a modified Dietary Approach to Stop Hypertension diet reduces systolic blood pressure, need for antihypertensive medications, body-mass index at three months post intervention compared to a modified Dietary Approach to Stop Hypertension diet alone. Fasting alters the gut microbiome, impacting bacterial taxa and gene modules associated with short-chain fatty acid production. Cross-system analyses reveal a positive correlation of circulating mucosa-associated invariant T cells, non-classical monocytes and CD4+ effector T cells with systolic blood pressure. Furthermore, regulatory T cells positively correlate with body-mass index and weight. Machine learning analysis of baseline immunome or microbiome data predicts sustained systolic blood pressure response within the fasting group, identifying CD8+ effector T cells, Th17 cells and regulatory T cells or Desulfovibrionaceae, Hydrogenoanaerobacterium, Akkermansia, and Ruminococcaceae as important contributors to the model. Here we report that the high-resolution multi-omics data highlight fasting as a promising non-pharmacological intervention for the treatment of high blood pressure in metabolic syndrome patients.
CitationNat Commun. 2021 Mar 30;12(1):1970. doi: 10.1038/s41467-021-22097-0.
AffiliationHZI,Helmholtz-Zentrum für Infektionsforschung GmbH, Inhoffenstr. 7,38124 Braunschweig, Germany.
The following license files are associated with this item:
- Creative Commons
- Gut microbiome of a porcine model of metabolic syndrome and HF-pEF.
- Authors: O'Donovan AN, Herisson FM, Fouhy F, Ryan PM, Whelan D, Johnson CN, Cluzel G, Ross RP, Stanton C, Caplice NM
- Issue date: 2020 Mar 1
- A Korean-Style Balanced Diet Has a Potential Connection with <i>Ruminococcaceae</i> Enterotype and Reduction of Metabolic Syndrome Incidence in Korean Adults.
- Authors: Wu X, Unno T, Kang S, Park S
- Issue date: 2021 Feb 3
- Relationship between fatty acids intake and Clostridium coccoides in obese individuals with metabolic syndrome.
- Authors: Jamar G, Santamarina AB, Dias GC, Masquio DCL, de Rosso VV, Pisani LP
- Issue date: 2018 Nov
- Gut Microbiota and Fecal Levels of Short-Chain Fatty Acids Differ Upon 24-Hour Blood Pressure Levels in Men.
- Authors: Huart J, Leenders J, Taminiau B, Descy J, Saint-Remy A, Daube G, Krzesinski JM, Melin P, de Tullio P, Jouret F
- Issue date: 2019 Oct
- Interplay between dietary phenolic compound intake and the human gut microbiome in hypertension: A cross-sectional study.
- Authors: Calderón-Pérez L, Llauradó E, Companys J, Pla-Pagà L, Pedret A, Rubió L, Gosalbes MJ, Yuste S, Solà R, Valls RM
- Issue date: 2021 May 15